Font size

February 2020

At the initiative of IMP a group of specialists, researchers and clinicians carried out a study into the safety of medicines in mitochondrial patients. The existing information needed a major update due to more scientific insights and clinical experience. IMP was convinced that this update needed to be based on a thorough scientific study. The study took place on an international level and with input from different disciplines in order to ensure a broadly based scientific outcome.

A publication in the Journal of Inherited Metabolic Disease (JIMD) was realized. And now a special text for patients and their families based on this is available.

IMP is grateful to all those specialists who were willing to dedicate their time and knowledge to this subject. The final result is of great importance to many mitochondrial patients and their families.

For the scientific publication click here.

For the text and tables for patients click here.

© 2020 Int. Mito Patients